Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving viable micro-organism
Patent
1996-09-27
1999-04-27
Feisee, Lila
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving viable micro-organism
435375, 435377, 435 4, 4242771, 514 12, C12N 1585
Patent
active
058979921
ABSTRACT:
The present invention relates to a method of identifying a compound (agent) which modulates apoptosis in transformed cells. In one embodiment, the invention is a method of identifying a compound which selectively activates apoptosis in transformed cells. In an alternative embodiment, the present invention can be used as a method of identifying a compound which inhibits apoptosis in cells. The invention also relates to a method of selectively killing transformed cells, wherein the transformed cell is contacted with a compound which selectively activates apoptosis in transformed cells, as described herein. The invention also relates to methods of treating diseases associated with defective apoptotic machinery (e.g., cancer, neurodegenerative disease). The methods of the present invention are useful for defining the biochemical mechanisms of apoptosis. In addition, the invention provides an assay to identify compounds which modulate (inhibit, activate) apoptosis, supplying new drugs which target defective apoptotic machinery associated with disease (e.g., cancer, neurodegenerative diseases such as Huntington's Disease and Alzheimers Disease).
REFERENCES:
Martin et al Cell vol. 82 349-352 Aug. 1995.
Boulakia et al Oncogene vol. 12 529-535 1996.
Fernandes-Alnemri et al Cancer Research vol. 55 6045-6052 Dec. 1995.
Kumar et al Trends in Biochem Sci vol. 20 198-202 1995.
Nunez et al Trends in Cell Cbiology vol. 4 399-403 Nov. 1994.
Sabbatini et al Cel Growth and Differentiation vol. 8 643-653 Jun. 1997.
McCurrch et al Proc Natl Acad Sci USA vol. 94 2345-2349 Mar. 1994.
O'Fearnhead et al Genes and Development vol. 11 1266-1267 1997.
Watabe et al J Biol Chem vol. 271 No 24 14067-14073 Jun. 1996.
Faleiro et al EMBO Journal vol. 16 No. 9 2271-2281 1997.
Enari, M. et al., "Apoptosis by a cytosolic extract from Fas-activated cells" The EMBO J., 14(21) :5201-5208 (1995).
Nicholson, D.W., et al., "Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis", Nature, 376:37-43 (1995).
Lazebnik, Y.A., et al., "Nuclear Events of Apoptosis In Vitro in Cell-free Mitotic Extracts: A Model System for Analysis of the Active Phase of Apoptosis", Jour. of Cell Biol., 123(1):7-22, (1993).
Newmeyer, D.D. et al., "Cell-Free Apoptosis in Xenopus Egg Extracts: Inhibition by Bcl-2 and Requirement for an Organelle Fraction Enriched in Mitochondria", Cell, 79:353-364, (1994).
Cosulich, S.C., et al., "Bcl-2 regulates activation of apoptotic proteases in a cell-free system", Current Biology, 6(8):997-1005, (1996).
Lazebnik, Y.A., et al., "Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE", Nature, 371:346-347, (1994).
Enari, M., et al., "Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis" Nature, 380:723-426, (1996).
Martin, S.J., et al., "Cell-free reconstitution of Fas-, UV radiation-and ceramide-induced apoptosis", The EMBO Jour., 14(21):5191-5200, (1995).
Fisher, D.E., "Apoptosis in Cancer Therapy: Crossing the Threshold", Cell, 78:539-542 (1994).
Goldstein, W., "Apoptosis, When Suicide is Good" Harbor Transcript, A Newsletter of Cold Spring Harbor Laboratory, 14(1):1, 4-6, (1996).
Liu, Xuesong, et al., "Induction of Apoptotic Program in Cell-Free Extracts: Requirements for dATP and Cytochrome c", Cell, 86:147-157, (1996).
Lazebnik, Y.A., et al., "Studies of the lamin proteinase reveal multiple parallel biochemical pathways during apoptotic execution", Proc. Natl. Acad. Sci. USA, 92:9042-9046, (1995).
Lowe, S.W., et al., "p53-Dependent Apoptosis Modulates the Cytotoxicity of Anticancer Agents", Cell, 74,:957-967, (1993).
Rao, L. et al., "The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19kDa and Bcl-2 proteins", Proc. Natl. Acad. Sci. USA, 89:7742-7746, (1992).
Lowe, S.W., and Ruley, H.E., "Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis", Genes & Development, 7:535-545, (1993).
Lowe, S.W., et al., "Abrogation of oncogene-associated apoptosis allows transformation of p53-deficient cells", Proc. Natl. Acad. Sci. USA, 91:2026-2030 (1994).
Lazebnik, Y.A., et al. "Characterization of the execution phase of apoptosis in vitro using extracts from condemned-phase cells", Journal of Cell Science, Supplement, 19:41-49 (1995).
White, E., "Life, death, and the pursuit of apoptosis", Genes & Development, 10:1-15, (1996).
Chinnaiyan, A.R. et al., "Molecular Ordering of the Cell Death Pathway", Jour. of Biol. Chem., 271:9:4573-4576, (1996).
Fearnhead Howard O.
Lazebnik Yuri
Lowe Scott William
McCurrach Mila Elena
Cold Spring Harbor Laboratory
Feisee Lila
Reeves Julie E
LandOfFree
Cell-free assay using oncogene-induced apoptosis in drug-resista does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cell-free assay using oncogene-induced apoptosis in drug-resista, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cell-free assay using oncogene-induced apoptosis in drug-resista will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-685503